Sun Pharma Shares Rally 9% after $11.75 Bn Organon Acquisition
Published on: April 27, 2026, 3:05 p.m. | Source: Outlook Business
Sun Pharma shares jumped 9% after India’s largest drugmaker by market value announced an all-cash $11.75 billion acquisition of US-based Organon & Co, boosting its women’s health and biosimilars portfolio and propelling the combined company into the top 25 global pharmaceutical players by revenue.
